Blog
24 May, 2019
Source: www.farmaindustria.es Scientific research in general, and biomedical research in particular, are activities of general public interest, given the benefits they bring to society as a […]
2 May, 2019
It reveals the diversity of cancer and immune cells in the tumor ecosystem, with the aim of better selecting treatments. Source: immedicohospitalario.es Investigadores University of Zurich […]
29 April, 2019
Source: immedicohospitalario.es The regulatory ecosystem for the protection of intellectual property in Europe works. The set of laws, regulations and incentives developed by the European Union […]
12 April, 2019
Source: Redaccionmedica.com The Spanish Agency of Medicines and Health Products has presented its Strategic Plan 2019-2022 that includes a total of 11 measures that aim to […]
11 April, 2019
Source: Immedicohospitalario.es The carrying out of clinical trials in Spanish hospitals and research centers has very positive consequences for the agents involved. For the health system, […]
9 April, 2019
Source: Farmaindustria.es Have highly qualified, motivated and experienced professionals, have the ability to achieve patient participation and have processes digitized as electronic medical records. These are […]
19 March, 2019
Source: actasanitaria.com The pharmaceutical company Roche has announced the launch of a new platform for clinical trials that is designed with the needs of patients throughout […]
15 March, 2019
Source: actasanitaria.com On March 14, the 39th Symposium of the Spanish Association of Pharmaceutical Industry (AEFI) began in Barcelona, ??under the theme ‘Tracings and in contact […]
13 March, 2019
Source: actasanitaria.com During a debate at the 7th Forum of the Foundation for Excellence and Quality of Oncology (ECO) held in Madrid, the president of Farmaindustria, […]
12 March, 2019
Source: farmaindustria.es In less than three decades Spain has experienced an unprecedented advance in biomedical research, to be placed in the group of countries with better […]
7 March, 2019
Source: actasanitaria.com The Spanish Agency for Medicines and Healthcare Products (AEMPS) has informed about the possibility of requesting the temporary exemption from the obligation to carry […]
27 February, 2019
Source: diariomedico.com This Tuesday the institutional working group of the plan on T-CAR therapies in the SNS meets. At the entrance of the meeting, the Minister […]
25 February, 2019
Source: Farmaindustria.es “In this country we have a first-line healthcare system, well-trained health professionals, excellent research centers, committed patient organizations and pioneering legislation in Europe. Along […]
22 February, 2019
Source: Farmaindustria.es Representatives of the Spanish Agency of Medicines and Health Products, research teams, pharmaceutical industry and patient organizations agree on the opportunity and need to […]
19 February, 2019
One of every six clinical trials that is carried out in Spain is already to investigate orphan drugs
Source: farmaindustria.es The commitment of the pharmaceutical industry to the research and development of treatments for rare diseases is indisputable and, as the data show, growing. […]
13 February, 2019
Source: Farmaindustria.es Various facts and arguments support the condition of Spain as an attractive country for the development of biopharmaceutical research projects: the quality of its […]
12 February, 2019
Source: Farmaindustria.es Investigate and develop new medicines more and more precise and effective, facilitate the access of patients to these innovative drugs in an environment of […]
22 January, 2019
Source: actasanitaria.com The Health Institute Carlos III (ISCIII) has announced that, through European programs, has “about five million euros” to participate in the latest calls open […]
14 January, 2019
Source: actasanitaria.com The Spanish Agency for Medicines and Healthcare Products (AEMPS) has published the correction of errors of version 10 of the document of instructions for […]
8 January, 2019
Source: Immedicohospitalario.es Bellicum Pharma has reported the preliminary results of its phase I / II dose escalation study in 12 patients with metastatic pancreatic cancer treated […]
26 December, 2018
Source: Immedicohospitalario.es The studies published by the CNIC scientists during the year 2017 consolidate this center as an institution of Spanish and international research excellence, highlighting […]
20 December, 2018
Source: immedicohospitalario.es Researchers from the universities of Vienna and Lancaster have developed a method aimed at improving precision medicine already during the clinical development phase of […]
14 December, 2018
Source: redaccionmedica.com A common medication for diabetes, combined with a drug against high blood pressure, is able to inhibit the growth of tumorese induce the death […]
12 December, 2018
Source: immedicohospitalario.es Systemic lupus erythematosus (SLE) is an autoimmune disease with multifaceted and extremely variable clinical manifestations, characterized by relapses and outbreaks followed by periods of […]
4 December, 2018
Source: Laverdad.es Spain has become the second country in the world where more clinical trials are carried out, only surpassed by the United States, the hegemonic […]
29 November, 2018
Source: redaccionmedica.com Different Spanish biotechnology companies and research groups presented on Wednesday a total of nine advanced innovative drug development projects to representatives of 17 national […]
22 November, 2018
Source: actasanitaria.com Researchers from the Health Research Institute of the Hospital Clínico de Valencia (INCLIVA) have shown that a molecule used to treat cancer, called PD033299, […]
20 November, 2018
Source: redaccionmedica.com The great results obtained with CAR-T therapies in cancer patients in whom chemotherapy has failed have focused the day ‘Towards a greater knowledge of […]
16 November, 2018
Source: redaccionmedica.com AstraZeneca has presented new analyzes of the Pegasus-Timi 54 trial in the framework of the Scientific Conferences of the American Heart Association. These findings […]
15 November, 2018
Source: actasanitaria.com A day after knowing the draft agreement on Brexit that last Tuesday, November 13, reached the European Union (EU) and the British Government, the […]
24 October, 2023
On World Disease Day, which is celebrated on October 19, Farmaindustria remembers the importance of clinical trials, the previous step for the arrival of innovative treatments […]
17 October, 2023
The document proposes, without the need for a regulatory change, a procedure that would allow the equitable arrival of drugs that meet certain criteria that make […]
11 October, 2023
elglobal.es In a political context with elections called for the European Parliament at the beginning of June 2024 and with Spain holding the presidency of […]
9 October, 2023
Between 2020 and 2022, 446 clinical trials with children and adolescents were conducted in our country, almost half of them focused on rare diseases and 90.4% […]
4 October, 2023
In recent years, the number of applications capable of interacting with patients to prevent, manage or treat diseases has increased, and which can also generate data […]
2 October, 2023
The 7th Congress of Patients’ Organisations, organised by the POP, analyses the application of the new European Regulation on Clinical Trials. Farmaindustria’s director general, Juan Yermo, […]
26 September, 2023
The vast majority of them are aimed at modifying the course of the disease, according to an Iqvia report on the future of R&D. In Spain […]
19 September, 2023
Only 7.5% are carried out in health centres. In order to alleviate this situation, Farmaindustria has presented a programme to promote them in outpatient clinics. Source: […]
14 September, 2023
“We are going to create a favourable environment”. This statement by José Manuel Miñones is the first step towards a roadmap that would highlight the key […]
12 September, 2023
“We must take advantage of the opportunity provided by the Spanish Presidency of the Council of the EU to include health, medicines and the innovative pharmaceutical […]
25 July, 2023
Over the next five years, the number of cancer treatments consisting of more than one drug will double, with 68 authorisations expected to be granted The […]
18 July, 2023
The forum, organised by the Menéndez Pelayo International University (UIMP) and Farmaindustria, will be held on 7 and 8 September in Santander Patient representatives, drug authorities, […]
